Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Alexion

Alexion Pharmaceuticals

Rank: 34

Boston, USA
alexion.com

2020 Revenues ($USD) : $6,070,000,000
2020 R&D spend : $68,600,000
2020 Number of Employees : 3,800
Fiscal Year End : 12/31/2020
Key People : Ludwig N. Hantson, CEO

Looking to expand its offerings in the immunology space, AstraZeneca is in the process of acquiring Alexion in a $39 billion deal slated to close in Q3 2021.

Boston-based Alexion has been a pioneer when it comes to treatment of immune-mediated rare diseases caused by uncontrolled activation of the complement system, an important part of the immune system. The company is probably best known for Soliris (eculizumab), a first-in-class anti-complement component 5 monoclonal antibody used in many countries to treat people with paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uremic syndrome, generalized myasthenia gravis and neuromyelitis optica spectrum disorder. Alexion more recently launched Ultomiris (ravulizumab), a second-generation C5 monoclonal antibody that boasts a more convenient dosing regimen. –CN

Alexion

ULTOMIRIS (ravulizumab-cwvz) is one of the product offerings from Alexion.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE